Literature DB >> 1740239

Interleukin 1 protects hair follicles from cytarabine (ARA-C)-induced toxicity in vivo and in vitro.

J J Jimenez1, M E Sawaya, A A Yunis.   

Abstract

ImuVert, a biologic response modifier, and interleukin 1 (IL 1) have been shown to protect the young rat from alopecia induced by cytarabine (ARA-C). In the present study the inhibition by ARA-C of DNA synthesis in hair follicles (HFs) and the protective effect of ImuVert and IL 1 were investigated in vivo and in vitro. Both ImuVert and IL 1 were equally effective in protecting rats from ARA-C-induced alopecia. DNA synthesis in HFs isolated from ARA-C-treated animals was 10-20% of untreated controls. Follicles isolated from animals given either ImuVert or IL 1 before ARA-C exhibited normal DNA synthesis. In vitro, the incubation of normal rat HF with ARA-C resulted in 80% inhibition of [3H]-thymidine uptake. Preincubation of the follicles for 1 hr with IL 1 before the addition of ARA-C completely blocked the inhibition. Preincubation with imuVert, however, was less effective in blocking the inhibition from ARA-C.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1740239     DOI: 10.1096/fasebj.6.3.1740239

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  3 in total

1.  The Role of Platelet-Rich Plasma in the Prevention of Chemotherapy-Induced Alopecia.

Authors:  Christina A Stamatiou; Assuan Lens; Carmen I Perez; Sylvia Daunert; Joaquin J Jimenez
Journal:  Skin Appendage Disord       Date:  2019-11-06

Review 2.  Prevention and Treatment of Chemotherapy-Induced Alopecia.

Authors:  Alfredo Rossi; Gemma Caro; Maria Caterina Fortuna; Flavia Pigliacelli; Andrea D'Arino; Marta Carlesimo
Journal:  Dermatol Pract Concept       Date:  2020-06-29

3.  Wound healing protects against chemotherapy-induced alopecia in young rats via up-regulating interleukin-1β-mediated signaling.

Authors:  Olivera Stojadinovic; Tongyu C Wikramanayake; Alexandra C Villasante Fricke; Natalie C Yin; Liang Liang; Eleanor Hinde; Julia Escandon; Marjana Tomic-Canic; David M Ansell; Ralf Paus; Joaquin J Jimenez
Journal:  Heliyon       Date:  2017-05-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.